Allopurinol Tablet shortage
Not a nationwide shortage — Teva Pharmaceuticals has told the FDA it is discontinuing its allopurinol tablets.
- The FDA lists this under “To be discontinued” as of Nov 22, 2026: a company stopping its own product.
- 29 other companies sell the same medicine and have not reported a problem, so your pharmacy may be able to order another company’s version.
- Status
- FDA term: “To Be Discontinued”
- Products on the record
- 4
- Category
- First posted
- Feb 19, 2026
- Last updated
- Feb 19, 2026
- Medicaid use (2026)
This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD Compiled from public FDA (openFDA) and CMS (Medicaid) data sources. Editorial policy
The Bottom Line
Teva is stopping its allopurinol tablets, and the change may be permanent. The same medicine in 100 mg and 300 mg tablets is still listed by other makers that have not reported a shortage.
Don’t stop or change your therapy on your own — talk with your prescriber about the plan that fits you, and ask your pharmacist what’s actually available (see options).
Is Allopurinol Being Discontinued? Status as of Nov 22, 2026
Not as a whole, as of Nov 22, 2026. Teva Pharmaceuticals is stopping its own version only; 29 other companies still sell the same medicine and have not reported a problem. Your pharmacy may need to order another company’s version.
The charts count only the companies that reported this shortage to the FDA; companies that haven’t reported a problem are listed after them, and the Supply-Risk rating counts them too.
Availability of the Affected Products
From the FDA shortage report: 4 products
Is Every Strength Still Made?
A medicine often comes in several strengths, and more than one company may make each. This shows whether at least one company still makes each strength on the record: a company on the shortage report that still has supply, or another company that sells it.
2 of 2 strengths
- 100 mgStill made by a company
- 300 mgStill made by a company
Other Companies Listing the Same Medicine, Not Reporting a Shortage
Companies that list Allopurinol Tablet with the FDA and have not reported a shortage (not counted in the charts above).
- Mylan Pharmaceuticals Inc.
- Par Health USA, LLC
- Major Pharmaceuticals
- Rising Pharma Holdings, Inc.
- NorthStar RxLLC
- Accord Healthcare Inc.
- Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
- Unichem Pharmaceuticals (USA), Inc.
- Camber Pharmaceuticals, Inc.
- PD-Rx Pharmaceuticals, Inc.
- Aphena Pharma Solutions - Tennessee, LLC
- Safecor Health, LLC
- A-S Medication Solutions
- AvPAK
- Sun Pharmaceutical Industries, Inc.
- Dr. Reddy's Laboratories Limited
- Aurobindo Pharma Limited
- American Health Packaging
- St. Mary's Medical Park Pharmacy
- Chartwell RX, LLC
- Proficient Rx LP
- Bryant Ranch Prepack
- NuCare Pharmaceuticals, Inc.
- Leading Pharma, LLC
- REMEDYREPACK INC.
- Zydus Pharmaceuticals (USA) Inc.
- Florida Pharmaceutical Products, LLC
- Direct_Rx
- XLCare Pharmaceuticals Inc.
Shortage Timeline
- Feb 19, 2026 Discontinuation notice on file 4 of 4 products affected.
- Feb 19, 2026 First reported to the FDA 4 products first listed.
Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.
Which Allopurinol Products Are Affected, by Company
Only the companies that told the FDA about a supply problem are listed here, so other companies may still have stock (see Where else can I get allopurinol?).
Company: Teva Pharmaceuticals USA, Inc.
-
Allopurinol Tablet, 100 mg
- Strength
- 100 mg
- Availability
- Not stated
Notes: Discontinuation of the manufacture of the drug
-
Allopurinol Tablet, 300 mg
- Strength
- 300 mg
- Availability
- Not stated
Notes: Discontinuation of the manufacture of the drug
-
Allopurinol Tablet, 100 mg
- Strength
- 100 mg
- Availability
- Not stated
Notes: Discontinuation of the manufacture of the drug
-
Allopurinol Tablet, 300 mg
- Strength
- 300 mg
- Availability
- Not stated
Notes: Discontinuation of the manufacture of the drug
Why Is Teva Pharmaceuticals Discontinuing Allopurinol?
A note from Dr. Brian Staiger, PharmD · Written Nov 21, 2026
Here's what I can tell you from the FDA report. Teva Pharmaceuticals USA, Inc. has told the FDA that it is discontinuing the manufacture of its allopurinol tablets. That means Teva is stopping production of its own versions of this medicine, not necessarily the drug as a whole. The FDA did not list a specific reason code, and the report doesn't explain why Teva made this decision, so I can't tell you more about the cause.
The Teva products covered by this report are:
- Allopurinol 100 mg tablets (two listings, NDCs 0591-5543-01 and 0591-5543-10)
- Allopurinol 300 mg tablets (two listings, NDCs 0591-5544-01 and 0591-5544-05)
The report doesn't give any dates for when Teva's supply will run out, and it doesn't name any strength or package size that Teva will keep making. This report only reflects Teva's products. Other companies may make allopurinol, and they are listed elsewhere on the page.
What Should I Do If I Take Allopurinol?
A note from Dr. Brian Staiger, PharmD · Written Nov 21, 2026
Allopurinol tablets are currently on the FDA drug-shortage list. This listing comes from one manufacturer, Teva, which reports that it is stopping production of its allopurinol tablets. The overall supply risk is rated low.
Both strengths in this report, 100 mg and 300 mg, are affected. Teva no longer lists supply for either one. However, other companies that did not report a shortage still list both strengths. Right now, no strength is without a listed source. Teva's reason is that it is discontinuing manufacture, so its part of this supply problem may be permanent. If you have been getting Teva's version, it is a good idea to plan ahead with your pharmacy and prescriber.
What you can do:
- Do not stop, skip, or change your dose on your own.
- Ask your pharmacy to order your strength. Pharmacies can check wholesalers and other manufacturers.
- The same medicine may be available from other makers, such as Mylan, Par Health, Major, Rising, NorthStar, or Accord. Your pharmacy may be able to get one of these, but it may not be in local stock.
- If your exact strength cannot be found, ask your prescriber or pharmacist about options. One example is combining a different strength to make up your dose.
- Manufacturer phone numbers are listed on this page for reference. Pharmacies usually handle these calls.
This information comes from national, manufacturer-reported FDA data and may not match your local pharmacy's stock. It is not personal medical advice.
Quick checklist for the pharmacy counter
- Ask your pharmacy to check other companies’ versions, other strengths, package sizes, and nearby stores — the options below are a starting point.
- If this is part of an ongoing or essential regimen (for example HIV, seizure, heart, transplant, diabetes or mental-health medicines), arrange continued supply before you run out rather than rationing doses.
Where Else Can I Get Allopurinol?
From the current FDA NDC Directory: the same medicine from companies that have not reported a shortage.
- Some listings are repackagers, which relabel another company’s product.
- A listing is not stock: these may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.
Same Medicine From Other Companies (Not Reporting a Shortage)
The same active ingredient, dosage form and route, from companies that have not reported a shortage to the FDA.
| Product | Strength | Form / route | Company | NDC |
|---|---|---|---|---|
| Allopurinol | 100 mg | Tablet · Oral | Mylan Pharmaceuticals Inc. | 00378-0137-01 |
| Allopurinol | 300 mg | Tablet · Oral | Mylan Pharmaceuticals Inc. | 00378-0181-01 |
| Allopurinol | 100 mg | Tablet · Oral | Par Health USA, LLC | 00603-2115-21 |
| Allopurinol | 300 mg | Tablet · Oral | Par Health USA, LLC | 00603-2116-21 |
| Allopurinol | 300 mg | Tablet · Oral | Major Pharmaceuticals | 00904-6572-61 |
| Allopurinol | 100 mg | Tablet · Oral | Major Pharmaceuticals | 00904-7041-61 |
| Allopurinol | 100 mg | Tablet · Oral | Rising Pharma Holdings, Inc. | 16571-0883-01 |
| Allopurinol | 200 mg | Tablet · Oral | Rising Pharma Holdings, Inc. | 16571-0884-01 |
| Allopurinol | 300 mg | Tablet · Oral | Rising Pharma Holdings, Inc. | 16571-0885-01 |
| Allopurinol | 100 mg | Tablet · Oral | NorthStar RxLLC | 16714-0576-01 |
| Allopurinol | 300 mg | Tablet · Oral | NorthStar RxLLC | 16714-0577-01 |
| Allopurinol | 100 mg | Tablet · Oral | Accord Healthcare Inc. | 16729-0134-01 |
| Allopurinol | 300 mg | Tablet · Oral | Accord Healthcare Inc. | 16729-0135-01 |
| Allopurinol | 100 mg | Tablet · Oral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23155-0693-01 |
| Allopurinol | 300 mg | Tablet · Oral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23155-0694-01 |
| Allopurinol | 100 mg | Tablet · Oral | Unichem Pharmaceuticals (USA), Inc. | 29300-0349-01 |
| Allopurinol | 300 mg | Tablet · Oral | Unichem Pharmaceuticals (USA), Inc. | 29300-0350-01 |
| Allopurinol | 100 mg | Tablet · Oral | Camber Pharmaceuticals, Inc. | 31722-0252-01 |
| Allopurinol | 300 mg | Tablet · Oral | Camber Pharmaceuticals, Inc. | 31722-0253-01 |
| Allopurinol | 300 mg | Tablet · Oral | PD-Rx Pharmaceuticals, Inc. | 43063-0934-01 |
| Allopurinol | 100 mg | Tablet · Oral | PD-Rx Pharmaceuticals, Inc. | 43063-0935-01 |
| Allopurinol | 300 mg | Tablet · Oral | Aphena Pharma Solutions - Tennessee, LLC | 43353-0186-60 |
| Allopurinol | 100 mg | Tablet · Oral | Safecor Health, LLC | 48433-0002-20 |
| Allopurinol | 300 mg | Tablet · Oral | Safecor Health, LLC | 48433-0003-20 |
| Allopurinol | 100 mg | Tablet · Oral | A-S Medication Solutions | 50090-4662-03 |
| Allopurinol | 300 mg | Tablet · Oral | A-S Medication Solutions | 50090-4663-00 |
| Allopurinol | 100 mg | Tablet · Oral | AvPAK | 50268-0030-10 |
| Allopurinol | 300 mg | Tablet · Oral | AvPAK | 50268-0031-10 |
| Allopurinol | 100 mg | Tablet · Oral | Mylan Institutional Inc. | 51079-0205-20 |
| Allopurinol | 300 mg | Tablet · Oral | Mylan Institutional Inc. | 51079-0206-20 |
| Allopurinol | 100 mg | Tablet · Oral | Aphena Pharma Solutions - Tennessee, LLC | 53401-0019-60 |
| Allopurinol | 100 mg | Tablet · Oral | Sun Pharmaceutical Industries, Inc. | 53489-0156-01 |
| Allopurinol | 300 mg | Tablet · Oral | Sun Pharmaceutical Industries, Inc. | 53489-0157-01 |
| Allopurinol | 100 mg | Tablet · Oral | Dr. Reddy's Laboratories Limited | 55111-0729-01 |
| Allopurinol | 300 mg | Tablet · Oral | Dr. Reddy's Laboratories Limited | 55111-0730-01 |
| Allopurinol | 100 mg | Tablet · Oral | Aurobindo Pharma Limited | 59651-0285-01 |
| Allopurinol | 300 mg | Tablet · Oral | Aurobindo Pharma Limited | 59651-0286-01 |
| Allopurinol | 100 mg | Tablet · Oral | American Health Packaging | 60687-0677-01 |
| Allopurinol | 300 mg | Tablet · Oral | American Health Packaging | 60687-0688-01 |
| Allopurinol | 100 mg | Tablet · Oral | St. Mary's Medical Park Pharmacy | 60760-0656-90 |
| Allopurinol | 300 mg | Tablet · Oral | ST. MARY'S MEDICAL PARK PHARMACY | 60760-0722-90 |
| Allopurinol | 100 mg | Tablet · Oral | Chartwell RX, LLC | 62135-0516-31 |
| Allopurinol | 300 mg | Tablet · Oral | Chartwell RX, LLC | 62135-0517-31 |
| Allopurinol | 300 mg | Tablet · Oral | Proficient Rx LP | 63187-0240-30 |
| Allopurinol | 100 mg | Tablet · Oral | Proficient Rx LP | 63187-0463-30 |
| Allopurinol | 300 mg | Tablet · Oral | Bryant Ranch Prepack | 63629-1781-01 |
| Allopurinol | 100 mg | Tablet · Oral | Bryant Ranch Prepack | 63629-2111-01 |
| Allopurinol | 100 mg | Tablet · Oral | NuCare Pharmaceuticals, Inc. | 66267-0665-30 |
| Allopurinol | 100 mg | Tablet · Oral | Leading Pharma, LLC | 69315-0291-01 |
| Allopurinol | 300 mg | Tablet · Oral | Leading Pharma, LLC | 69315-0292-01 |
| Allopurinol | 200 mg | Tablet · Oral | Leading Pharma, LLC | 69315-0409-09 |
| Allopurinol | 100 mg | Tablet · Oral | REMEDYREPACK INC. | 70518-3660-00 |
| Allopurinol | 300 mg | Tablet · Oral | REMEDYREPACK INC. | 70518-3704-00 |
| Allopurinol | 100 mg | Tablet · Oral | Zydus Pharmaceuticals (USA) Inc. | 70710-1209-00 |
| Allopurinol | 300 mg | Tablet · Oral | Zydus Pharmaceuticals (USA) Inc. | 70710-1210-00 |
| Allopurinol | 200 mg | Tablet · Oral | Zydus Pharmaceuticals (USA) Inc. | 70710-2009-00 |
| Allopurinol | 100 mg | Tablet · Oral | Florida Pharmaceutical Products, LLC | 71921-0240-01 |
| Allopurinol | 200 mg | Tablet · Oral | Florida Pharmaceutical Products, LLC | 71921-0241-09 |
| Allopurinol | 300 mg | Tablet · Oral | Florida Pharmaceutical Products, LLC | 71921-0242-01 |
| Allopurinol | 300 mg | Tablet · Oral | Direct_Rx | 72189-0417-30 |
| Allopurinol | 100 mg | Tablet · Oral | Direct_Rx | 72189-0437-30 |
| Allopurinol | 100 mg | Tablet · Oral | XLCare Pharmaceuticals Inc. | 72865-0303-01 |
| Allopurinol | 300 mg | Tablet · Oral | XLCare Pharmaceuticals Inc. | 72865-0304-01 |
Therapeutic Equivalents and Pricing 30 products
Other products the FDA rates as interchangeable with the affected strengths, with what pharmacies pay for each and whether pharmacies are still buying it. Cheapest first.
| Product | Manufacturer | Package | Pharmacy cost per unit (NADAC) | FDA rated equivalent | Availability |
|---|---|---|---|---|---|
| Allopurinol 100 mgNDC 00591-5543-01 | Actavis | 100 tablets | $0.032 | — | Discontinued |
| Allopurinol 100 mgNDC 00378-0137-01 | Mylan | 100 tablets | $0.032 | AB | Availability likely |
| Allopurinol 100 mgNDC 00591-5543-10 | Actavis | 1000 tablets | $0.032 | — | Availability likely |
| Allopurinol 100 mgNDC 00603-2115-21 | Par | 100 tablets | $0.032 | AB | Availability likely |
| Allopurinol 100 mgNDC 00904-7041-61 | Major | 100 tablets | $0.032 | AB | Availability likely |
| Allopurinol 100 mgNDC 16571-0883-09 | Rising | 90 tablets | $0.032 | AB | Availability likely |
| Allopurinol 100 mgNDC 16714-0576-01 | NorthStar | 30 tablets | $0.032 | AB | Availability likely |
| Allopurinol 100 mgNDC 23155-0693-01 | Heritage | 100 tablets | $0.032 | AB | Availability likely |
| Allopurinol 100 mgNDC 29300-0349-01 | Unichem | 100 tablets | $0.032 | AB | Availability likely |
| Allopurinol 100 mgNDC 31722-0252-01 | Camber | 100 tablets | $0.032 | AB | Availability likely |
| Allopurinol 100 mgNDC 51079-0205-20 | Mylan | 100 tablets | $0.032 | AB | Availability likely |
| Allopurinol 100 mgNDC 53489-0156-01 | Sun | 100 tablets | $0.032 | AB | Availability likely |
| Allopurinol 100 mgNDC 55111-0729-01 | Dr. | 100 tablets | $0.032 | AB | Availability likely |
| Allopurinol 100 mgNDC 59651-0285-01 | Aurobindo | 100 tablets | $0.032 | AB | Availability likely |
| Allopurinol 100 mgNDC 60687-0677-01 | American | 100 tablets | $0.032 | AB | Availability likely |
| Allopurinol 100 mgNDC 62135-0516-31 | Chartwell | 300 tablets | $0.032 | AB | Availability likely |
| Allopurinol 100 mgNDC 69315-0291-01 | Leading | 100 tablets | $0.032 | AB | Availability likely |
| Allopurinol 100 mgNDC 70710-1209-00 | Zydus | 1000 tablets | $0.032 | AB | Availability likely |
| Allopurinol 100 mgNDC 71921-0240-01 | Florida | 100 tablets | $0.032 | AB | Availability likely |
| Allopurinol 100 mgNDC 16729-0134-01 | Accord | 100 tablets | $0.033+4% | AB | FDA listed |
| Allopurinol 300 mgNDC 00378-0181-01 | Mylan | 100 tablets | $0.052 | AB | Availability likely |
| Allopurinol 300 mgNDC 00591-5544-05 | Actavis | 500 tablets | $0.052 | — | Availability likely |
| Allopurinol 300 mgNDC 00603-2116-21 | Par | 100 tablets | $0.052 | AB | Availability likely |
| Allopurinol 300 mgNDC 00904-6572-61 | Major | 100 tablets | $0.052 | AB | Availability likely |
| Allopurinol 300 mgNDC 16571-0885-09 | Rising | 90 tablets | $0.052 | AB | Availability likely |
| Allopurinol 300 mgNDC 16714-0577-01 | NorthStar | 100 tablets | $0.052 | AB | Availability likely |
| Allopurinol 300 mgNDC 23155-0694-01 | Heritage | 100 tablets | $0.052 | AB | Discontinued |
| Allopurinol 300 mgNDC 29300-0350-01 | Unichem | 100 tablets | $0.052 | AB | Availability likely |
| Allopurinol 300 mgNDC 31722-0253-01 | Camber | 100 tablets | $0.052 | AB | Availability likely |
| Allopurinol 300 mgNDC 51079-0206-20 | Mylan | 100 tablets | $0.052 | AB | Availability likely |
These have the same ingredient, strength, form and route, and the FDA rates them as substitutes (an “AB” rating in its Orange Book). The price is what pharmacies pay on average (CMS’s NADAC survey), not what you pay. Availability comes from recent pharmacy prices, not a stock check.
Other Drugs in the Same Treatment Class
These are different medicines — not other versions of allopurinol — that fall in the same broad treatment class (hyperuricemia tx - xanthine oxidase inhibitors). They are not automatic substitutes: they can differ in how they work, dosing, effectiveness, side effects and what they’re approved to treat. Do not switch on your own. This list is for information only — ask your prescriber or pharmacist whether any of them is appropriate for you.
Codes & Classification for pharmacists and billers
- GCN Seq No
- 002535
- GCN
- 07070
- HICL code
- 001100
- Ingredient (HICL)
- Allopurinol
- HIC1 code
- C
- Therapeutic class — broad (HIC1)
- Electrolyte Balance/Metabolism/Nutrition
- HIC2 code
- C7
- Therapeutic class — intermediate (HIC2)
- Metabolic Inhibitors And Stimulants
- HIC3 code
- C7A
- Therapeutic class — specific (HIC3)
- Hyperuricemia Tx - Xanthine Oxidase Inhibitors
- AHFS code
- 92:16.00.00
- AHFS class
- Antigout Agents
- FDB label name
- ALLOPURINOL 100 MG TABLET
- FDB brand name
- Allopurinol
- Legend status
- F — Federal legend — prescription drug or device
Where does this data come from? Identity codes come from First Databank (FDB) (HICL ingredient, HIC1–3 therapeutic-class hierarchy, GCN, AHFS class, legend status) and Medi-Span GPI, mapped from a representative affected NDC. Licensed reference data — for identification only.
Allopurinol Shortage FAQs
Is allopurinol discontinued?
Only Teva Pharmaceuticals’s version. Teva Pharmaceuticals has told the FDA it is stopping its own product (listed under “To be discontinued” as of Nov 22, 2026), while 29 other companies still sell the same medicine and have not reported a problem (Mylan Pharmaceuticals, Par Health, Major Pharmaceuticals and 26 more). It is not a nationwide shortage.
Which strengths of allopurinol are affected?
The FDA record covers 2 strengths: 100 mg, 300 mg. Every strength on the record is still made by at least one company, though stock varies by pharmacy.
Which allopurinol products are affected?
Allopurinol Tablet, 100 mg (NDC 00591-5543-10); Allopurinol Tablet, 300 mg (NDC 00591-5544-05); Allopurinol Tablet, 100 mg (NDC 00591-5543-01) and 1 more. The full per-NDC list (availability, company and status) is in the table above — each NDC links to its own page.
When will allopurinol be available again?
A discontinuation is usually permanent for that company’s product. The same medicine is still sold by Mylan Pharmaceuticals, Par Health, Major Pharmaceuticals and 26 more, so ask your pharmacy to order another company’s version.
Can I still get allopurinol somewhere?
Other companies (Mylan Pharmaceuticals, Par Health, Major Pharmaceuticals and 26 more) sell the same medicine and have not reported a problem. See “Where else can I get allopurinol?” above — stock still varies by pharmacy.
What should I do if I take allopurinol?
Don’t stop or change it on your own. Ask your pharmacist whether they can order it from another company or a different strength or package size, and ask your prescriber about a long-term plan before your supply runs out.
How to Read the Supply-Risk Rating
Each drug in shortage gets one point for each of five risk factors that apply to it (listed with its rating). It is our estimate across the country, not a check of your pharmacy’s shelves.
- Low0 to 2 risk factors Your pharmacy can often still get it, though it may need to be ordered.Allopurinol is rated Low: 0 of 5 risk factors.
- Medium3 risk factors Supply is tight in several ways. Finding it may take some calling around.
- High4 or 5 risk factors, or no company found making it Few companies are left making it, or some strengths have no maker at all. It may be hard to find for a while.
Back to this drug’s rating ↑ · How we rate supply risk, in full
Where This Data Comes From
- The FDA’s drug shortage database, checked every day: the companies, their products and the codes on their boxes (NDCs), the status, the reason and the dates. See the FDA’s record for this shortage ↗
- The FDA’s NDC Directory: the other companies that make the same medicine, which the supply-risk rating counts.
- CMS Medicaid prescription data: how widely it is used. It counts Medicaid prescriptions only, so it is a rough guide, not total U.S. use.
- First Databank and CMS NADAC: matching the same medicine across companies, and what pharmacies pay for the equivalents.
For reference only. Check with your pharmacist, the drug’s maker or the FDA before acting on it.